Target intelligence / Profile preview

RNA, U6 small nuclear 527, pseudogene (RNU6-527P)

Target
RNU6-527P
Molecular classification
Other (pseudogene), Non-coding RNA derivative
01

Overview

RNU6-527P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene. U6 snRNA is a component of the spliceosome, which catalyzes mRNA splicing in eukaryotes[3][1]. However, pseudogenes like RNU6-527P do not produce functional RNA or protein. They arise typically via retrotransposition events such as LINE element-mediated reverse transcription, which copies cellular RNAs (including snRNAs) back into the genome[5]. These pseudogenes lack function in RNA processing or spliceosome formation and generally represent genomic fossils rather than active molecular entities. Many such U6-related pseudogenes exist in the human genome, reflecting the evolutionary importance of the parental U6 snRNA but serving no known functional or therapeutic role[5][4]. Key context: - The functional molecule is *U6 snRNA*, a crucial spliceosomal RNA involved in pre-mRNA splicing[1][3], not its numerous pseudogenes (such as RNU6-527P). - Pseudogenes are abundant in the genome but typically nonfunctional[4][5]. - RNU6-527P is not a drug target, diagnostic marker, or biomarker. - If you are seeking information about the *active* U6 snRNA, that is a spliceosomal RNA involved in intron removal and not related to drug targeting or classic molecular pharmacology[3].

Other names
RNU6-527PRNA, U6 small nuclear 527, pseudogene
02

Biological functions

Other (RNU6-527P does not have a known biological function, being a pseudogene; it does not mediate splicing or any other active process)
03

Disease associations

Other (No recognized disease roles; pseudogenes generally do not participate directly in disease, though rare cases exist where pseudogenes regulate gene expression, but not documented for RNU6-527P)

Beyond the preview

Go deeper on RNA, U6 small nuclear 527, pseudogene (RNU6-527P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 527, pseudogene (RNU6-527P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call